12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Prorenal: Development discontinued

Ono and partner Dainippon discontinued development of limaprost alfadex to treat carpal tunnel syndrome after the product failed to demonstrate efficacy in a Phase II trial....

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >